Metformin og obstetriske patienter

Katrine Dahl Pedersen; Nathalie Søderhamn Bülow; Kasper Aaboe; Julie Galsgaard; Helle Sand Odgaard; Elisabeth Reinhardt Mathiesen; Jeannet Lauenborg

Metformin og obstetriske patienter

Katrine Dahl Pedersen, Nathalie Søderhamn Bülow, Kasper Aaboe, Julie Galsgaard, Helle Sand Odgaard, Elisabeth Reinhardt Mathiesen, Jeannet Lauenborg

Institut for Klinisk Medicin

1 Citationer (Scopus)

Abstract

Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism.

Bidragets oversatte titel	Metformin and the obstetric patient
Originalsprog	Dansk
Artikelnummer	V05150438
Tidsskrift	Ugeskrift for Laeger
Vol/bind	177
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 7 dec. 2015

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

http://ugeskriftet.dk/files/V05150438_2.pdf

Citationsformater

@article{fb82e52b05ab452da074c8c7e7e57e60,

title = "Metformin og obstetriske patienter",

abstract = "Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism.",

author = "Pedersen, {Katrine Dahl} and B{\"u}low, {Nathalie S{\o}derhamn} and Kasper Aaboe and Julie Galsgaard and Odgaard, {Helle Sand} and Mathiesen, {Elisabeth Reinhardt} and Jeannet Lauenborg",

year = "2015",

month = dec,

day = "7",

language = "Dansk",

volume = "177",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Metformin og obstetriske patienter

AU - Pedersen, Katrine Dahl

AU - Bülow, Nathalie Søderhamn

AU - Aaboe, Kasper

AU - Galsgaard, Julie

AU - Odgaard, Helle Sand

AU - Mathiesen, Elisabeth Reinhardt

AU - Lauenborg, Jeannet

PY - 2015/12/7

Y1 - 2015/12/7

N2 - Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism.

AB - Polycystic ovary syndrome (PCOS) is associated with insulin resistance, infertility, obesity and gestational complications. Metformin is widely used in fertility treatment of women with PCOS, due to a suggested positive effect of continued metformin treatment beyond the first trimester on pregnancy complications. Larger randomized trials have failed to confirm this. Metformin treatment has not been found to be superior to insulin treatment in women with gestational diabetes and may be associated with long-term consequences in the children in the form of overweight and disturbed glucose metabolism.

M3 - Tidsskriftartikel

C2 - 26651913

SN - 0041-5782

VL - 177

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

M1 - V05150438

ER -

Metformin og obstetriske patienter

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater